1-1 of 1
Lewis Kay, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FV-162 Is a Novel Orally Bioavailable Proteasome Inhibitor With Improved Pharmacokinetics That Displays Preclinical Efficacy In Vitro and In Vivo

Zezhou Wang, PhD, Peter Dove, Xiaoming Wang, Carolyn A. Goard, PhD, Zhihua Li, Alex Nachman, Yoonsun Jenny Oh, Rose Hurren, Amy Ruschak, PhD, Shane Climie, PhD, David O'Neill, PhD, Barry Press, PhD, Carly Griffin, PhD, Elijus Undzys, Ahmed Aman, PhD, Rima Al-awar, PhD, Lewis Kay, PhD, Suzanne Trudel, MD, MSC, FRCPC, Malik Slassi, PhD, Aaron Schimmer, PhD, MD
Journal: Blood
Blood (2013) 122 (21): 1988.
https://doi.org/10.1182/blood.V122.21.1988.1988
Published: 2013